Skip to content

Rebecca Gordon

3 papers in the library · publishing 2023-2026

Papers

Sort Most recent Most cited

Quantitative multi-tissue profiling of tryptamines, phenethylamines, and β-carbolines across 53 species of Australian Acacia

Biochemical Systematics and Ecology October 7, 2026 Monique Anne Jacqueline McDonald, Matthew Nolan, Rebecca Gordon et al.

The genus Acacia , comprising approximately 1000 native Australian species, represents a major contributor to the biodiversity of the continent. Some species of Acacia are known to contain bioactive alkaloids, including the popular psychedelic N,N-dimethyltryptamine (DMT). However, systematic phytochemical characterisation across different species of Acacia and tissue types remains limited....

Does acute stress induced via cold water immersion increase blood THC concentrations in regular cannabis users?

Psychopharmacology December 2025 Danielle McCartney, Jordan Levoux, Rebecca Gordon et al.

RATIONALE: Δ9-tetrahydrocannabinol (THC), the principal intoxicant in cannabis, is a highly lipophilic substance that is readily stored in fat. Preclinical research suggests that fat-stored THC can be released into circulation under lipolytic conditions, such as stress. However, compelling evidence of this phenomenon is lacking in humans. OBJECTIVES: Here, we investigated the effects of acute...

DOI: 10.1007/s00213-025-06833-8 (opens in new tab) Full text (opens in new tab) Biomarkers Cannabinoid Cognition Drug testing +5

Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome.

NEJM evidence September 2023 Philip E Mosley, Lachlan Webb, Anastasia Suraev et al.

BACKGROUND: Tourette syndrome is characterized by chronic motor and vocal tics. There is preliminary evidence of benefit from cannabis products containing Δ9-tetrahydrocannabinol (THC) and that coadministration of cannabidiol (CBD) improves the side-effect profile and safety. METHODS: In this double-blind, crossover trial, participants with severe Tourette syndrome were randomly assigned to a...